Known for our work with a wide range of emerging companies, including in telemedicine, genomics, biologic products, medical devices, behavioral health, cannabis, and psychedelics, Leech Tishman has been closely linked to many of the most well-known innovative ventures across the healthcare and life sciences industries.

Due to our expertise in both FDA and state practice-of-medicine legal issues, our guidance has been critical to the launch of many telemedicine and next-generation health technology ventures. Our attorneys guide clients through the process, from start-up to mature company or acquisition target, providing unique insight regarding potential liquidity events.

Deeply immersed in the transformation and future of the U.S. healthcare system on a daily basis, our firm is uniquely positioned to advise start-up healthcare ventures regarding business operations, regulatory compliance, and the development of policies and procedures that legally protect the company and prioritize business growth.

We apply in-depth legal knowledge and experience to assess the federal and state regulatory issues inherent in new healthcare ventures, including corporate practice of medicine (CPOM), data privacy (HIPAA) and cybersecurity, Stark and Anti-Kickback concerns, and telemedicine.